Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promisemed Hangzhou Meditech CoBJSE:920069 18 PS Ratio is 3.50 as of Sep. 05, 2026, which is 7% below its 10-year median of 3.75. GuruFocus rates BJSE:920069 with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 803 Medical Devices & Instruments companies, Promisemed Hangzhou Meditech Co ranks worse than 56.79% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Promisemed Hangzhou Meditech Co's share price is ¥33.28.
Promisemed Hangzhou Meditech Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ¥9.51. Hence, Promisemed Hangzhou Meditech Co's PS Ratio for today is 3.50.
Good Sign:
Promisemed Hangzhou Meditech Co Ltd stock PS Ratio (=3.51) is close to 1-year low of 3.35.
The historical rank and industry rank for Promisemed Hangzhou Meditech Co's PS Ratio or its related term are showing as below:
BJSE:920069'
s PS Ratio Range Over the Past 10 Years
Min: 3.35 Med: 3.75 Max: 4.81
Current: 3.5
During the past 4 years, Promisemed Hangzhou Meditech Co's highest PS Ratio was 4.81. The lowest was 3.35. And the median was 3.75.
BJSE:920069's PS Ratio is ranked worse than 56.79% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 2.98
vs BJSE:920069: 3.50
During the past 4 years, Promisemed Hangzhou Meditech Co's highest 3-Year average Revenue per Share Growth Rate was 16.50% per year. The lowest was 16.50% per year. And the median was 16.50% per year.
Promisemed Hangzhou Meditech Co (BJSE:920069) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Promisemed Hangzhou Meditech Co PS Ratio Related Terms
Promisemed Hangzhou Meditech Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BJSE:920069 vs ISRG, BDX, RMD: PS Ratio Comparison
For the Medical Instruments & Supplies subindustry, Promisemed Hangzhou Meditech Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promisemed Hangzhou Meditech Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Promisemed Hangzhou Meditech Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Promisemed Hangzhou Meditech Co's PS Ratio falls into.
Promisemed Hangzhou Meditech Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Promisemed Hangzhou Meditech Co's Share Price of today is ¥33.28. Promisemed Hangzhou Meditech Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥9.51.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Promisemed Hangzhou Meditech Co (BJSE:920069) has a PS Ratio of 3.50 as of Sep. 05, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Promisemed Hangzhou Meditech Co and its competitors. This is near median its historical median of 3.75. Over the past decade, Promisemed Hangzhou Meditech Co's PS Ratio has ranged from 3.35 to 4.81. According to the industry distribution chart, Promisemed Hangzhou Meditech Co ranks #456 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 56.8%.
Is Promisemed Hangzhou Meditech Co's PS Ratio too high?
Promisemed Hangzhou Meditech Co's current PS Ratio of 3.50 is near median its 10-year median of 3.75. Over the past 10 years, this metric has ranged from a low of 3.35 to a high of 4.81. The Medical Devices & Instruments industry median PS Ratio is 2.98. Promisemed Hangzhou Meditech Co's value of 3.50 is 17.4% above this industry median. Based on the distribution chart, Promisemed Hangzhou Meditech Co ranks #456 out of 803 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Promisemed Hangzhou Meditech Co has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Promisemed Hangzhou Meditech Co's PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Promisemed Hangzhou Meditech Co ranks #456 out of 803 companies for PS Ratio. This places Promisemed Hangzhou Meditech Co in the lower half of its industry. The industry median PS Ratio is 2.98. Promisemed Hangzhou Meditech Co's value of 3.50 is 17.4% above this benchmark. Historically, Promisemed Hangzhou Meditech Co's own PS Ratio has ranged from 3.35 to 4.81 over the past decade. While the company's 10-year median is 3.75 vs. the industry median of 2.98, Promisemed Hangzhou Meditech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.98, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Promisemed Hangzhou Meditech Co's current PS Ratio of 3.50 is 17.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Promisemed Hangzhou Meditech Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promisemed Hangzhou Meditech Co's current PS Ratio is 3.50, which is near median its own 10-year median of 3.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisemed Hangzhou Meditech Co stock overvalued right now?
Promisemed Hangzhou Meditech Co (BJSE:920069) has a current PS Ratio of 3.50. The current PS Ratio is 3.50, which is near median its 10-year median of 3.75 and 17.4% above the Medical Devices & Instruments industry median of 2.98. Promisemed Hangzhou Meditech Co's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Promisemed Hangzhou Meditech Co (BJSE:920069), the current PS Ratio is 3.50 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Promisemed Hangzhou Meditech Co Ltd is engaged in the Research, development, production and sales of diabetes care, universal drug delivery and infusion, and minimally invasive interventional medical devices.
18GF Score
Get the complete analysis for BJSE:920069
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920069 has been successfully added to your 
